Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2025-12-25 @ 11:12 PM
Study NCT ID:
NCT03575793
Status:
COMPLETED
Last Update Posted:
2024-11-12
First Post:
2018-06-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
Sponsor:
Salma Sabbour
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-06
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-20
First Submit QC Date:
None
Study First Post Date:
2018-07-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-17
Results First Submit QC Date:
None
Results First Post Date:
2024-11-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-17
Last Update Post Date:
2024-11-12
Last Update Post Date Type:
ACTUAL